Javascript must be enabled to continue!
11 Years of CLINAM, the European Foundation for Clinical Nanomedicine
View through CrossRef
CLINAM is a nonprofit organization based in Basel, Switzerland (www.clinam.org), that has been founded by Beat Löffler and Patrick Hunziker in 2007. The organization, utilizing its worldwide network of stakeholders, hosts an annual European and Global Summit for Clinical Nanomedicine in the fields of nanomedicine, targeted drug delivery, precision medicine, and other related fields. These summits relate to the main elements of cutting-edge medicine and the inclusion of the implications of nanomedicine for patients and mankind. In 2009, CLINAM founded the International Society for Nanomedicine (ISNM) with the participation of scientists and national organizations from Japan, Korea, the USA, Canada, Europe, South America, India, Australia, Africa, Australia, and India. ISNM is led by another member country every 2 years. Every 2 years, ISNM organizes a summer school, which brings together experienced researchers and students. Another important element of CLINAM is the European Society for Nanomedicine (www.esnam.org), which has more than 1000 members today.
Title: 11 Years of CLINAM, the European Foundation for Clinical Nanomedicine
Description:
CLINAM is a nonprofit organization based in Basel, Switzerland (www.
clinam.
org), that has been founded by Beat Löffler and Patrick Hunziker in 2007.
The organization, utilizing its worldwide network of stakeholders, hosts an annual European and Global Summit for Clinical Nanomedicine in the fields of nanomedicine, targeted drug delivery, precision medicine, and other related fields.
These summits relate to the main elements of cutting-edge medicine and the inclusion of the implications of nanomedicine for patients and mankind.
In 2009, CLINAM founded the International Society for Nanomedicine (ISNM) with the participation of scientists and national organizations from Japan, Korea, the USA, Canada, Europe, South America, India, Australia, Africa, Australia, and India.
ISNM is led by another member country every 2 years.
Every 2 years, ISNM organizes a summer school, which brings together experienced researchers and students.
Another important element of CLINAM is the European Society for Nanomedicine (www.
esnam.
org), which has more than 1000 members today.
Related Results
The consolidation of nanomedicine
The consolidation of nanomedicine
AbstractOver the past two decades, nanomedicine has grown steadily, however, without inducing a palpable shift in the diagnosis and treatment of diseases so far. While this may sim...
Nanomedicine and ethics: is there anything new or unique?
Nanomedicine and ethics: is there anything new or unique?
AbstractAs medicine moves toward being able to predict what you will die from and when, nanomedicine is expected to enhance human capabilities and properties and promises the abili...
Building the European Nanomedicine Research and Innovation Area: 10 years funding innovative research projects
Building the European Nanomedicine Research and Innovation Area: 10 years funding innovative research projects
EuroNanoMed (ENM) is an ERA-NET for nanomedicine. ERA.NET is an EU funded network which had been established to support and increase the coordination of European research programme...
Precision Nanomedicine Volume 2 Issue 2 Table of Contents
Precision Nanomedicine Volume 2 Issue 2 Table of Contents
Prec. Nanomed. 2019 Apr;2(2):270-277, EDITORIAL
It has been 10 years since the establishment of EuroNanoMed (ENM), presently in its third phase. For those 10 years, research and in...
Recent Breakthroughs of Nanomedicine in Medical Fields
Recent Breakthroughs of Nanomedicine in Medical Fields
Nanomedicine refers to the application of nanoparticles for disease diagnosis and treatment. Recent progresses in nanomedicine have demonstrated significant breakthroughs in enhanc...
Energy‐Converting Nanomedicine
Energy‐Converting Nanomedicine
AbstractSerious side effects to surrounding normal tissues and unsatisfactory therapeutic efficacy hamper the further clinic applications of conventional cancer‐therapeutic strateg...
Challenges in Development of Nanomedicine for Treatment of Cancer
Challenges in Development of Nanomedicine for Treatment of Cancer
The inherent limitations of conventional cancer therapies have stimulated the growth of cancer nanomedicine. This is primarily attributable to its unique features for drug delivery...
Nanomedicine in Focus
Nanomedicine in Focus
Nanomedicine is the application of nanotechnology in the field of medicine, comprising the utilization of materials at the nanoscale for purposes such as disease diagnosis, prevent...

